These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7203940)

  • 61. New media. Experience from 10 years of development of water-soluble nonionic contrast media.
    Almén T
    Invest Radiol; 1980; 15(6 Suppl):S283-8. PubMed ID: 7203936
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Excretory urography--current indications of the status of a conventional diagnostic method. Status of nonionic and ionic contrast media].
    Porst H; Mayer R
    Fortschr Med; 1985 Aug; 103(30):755-8. PubMed ID: 4043912
    [No Abstract]   [Full Text] [Related]  

  • 63. [Clinical uses of iopamidol].
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):701-816. PubMed ID: 6670825
    [No Abstract]   [Full Text] [Related]  

  • 64. [Use of iopamidol in pulmonary angiography].
    Marache P
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):764-8. PubMed ID: 6670838
    [No Abstract]   [Full Text] [Related]  

  • 65. Clinical superiority of a new nonionic contrast agent (iopamidol) for cardiac angiography.
    Gertz EW; Wisneski JA; Chiu D; Akin JR; Hu C
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):250-8. PubMed ID: 3881496
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Iopamidol compared with Isopaque Cerebral in angiography of the lower extremities].
    Aspestrand F
    Tidsskr Nor Laegeforen; 1984 Nov; 104(31):2164-5. PubMed ID: 6397873
    [No Abstract]   [Full Text] [Related]  

  • 67. Urographic excretion studies with nonionic contrast agents. Iopamidol vs. iothalamate.
    Wilcox J; Evill CA; Sage MR; Benness GT
    Invest Radiol; 1983; 18(2):207-10. PubMed ID: 6862812
    [No Abstract]   [Full Text] [Related]  

  • 68. [Use of a new iodized contrast medium: iopamidol, for the performance of rapid injections in whole-body computed x-ray tomography (dynamic-scan)].
    Rieux D; Vialle M; Caron-Poitreau C
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):809-11. PubMed ID: 6670846
    [No Abstract]   [Full Text] [Related]  

  • 69. New contrast agents. Chemistry and pharmacology.
    Dawson P
    Invest Radiol; 1984; 19(6 Suppl):S293-300. PubMed ID: 6511274
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical comparison of Hexabrix, iopamidol, and Urografin-60 in whole body computed tomography.
    Spataro RF; Fischer HW; Kormano M
    Invest Radiol; 1984; 19(6 Suppl):S372-5. PubMed ID: 6511276
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Histamine liberation through renal roentgen contrast media: comparison of iopamidol and meglumine ioglicinate].
    Gmeinwieser J; Reimann HJ; Reiser M
    Rontgenpraxis; 1985 Nov; 38(11):396-9. PubMed ID: 2417338
    [No Abstract]   [Full Text] [Related]  

  • 72. Development of nonionic contrast media.
    Almén T
    Invest Radiol; 1985; 20(1 Suppl):S2-9. PubMed ID: 2579043
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Contrast media for left ventricular angiography. A comparison between Cardio-Conray and iopamidol.
    Gwilt DJ; Nagle RE
    Br Heart J; 1984 Apr; 51(4):427-30. PubMed ID: 6200129
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Renal contrastography with rapid intravenous injection of Iopamidol].
    Bianchi SD; Granone A; Gatti G; Mecozzi B; Andretta L
    Radiol Med; 1981 Sep; 67(9):668-9. PubMed ID: 7313186
    [No Abstract]   [Full Text] [Related]  

  • 75. A comparative trial of sodium meglumine ioxaglate (Hexabrix) and iopamidol (Niopam) for cerebral angiography.
    Molyneux AJ; Sheldon PW; Yates DA
    Br J Radiol; 1982 Dec; 55(660):881-4. PubMed ID: 6756533
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stability of nonionic water-soluble contrast media: implications for their design.
    Sovak M; Ranganathan R
    Invest Radiol; 1980; 15(6 Suppl):S323-8. PubMed ID: 7203944
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of iopamidol, ioxaglate, and diatrizoate during coronary arteriography in dogs.
    Thomson KR; Evill CA; Fritzsche J; Benness GT
    Invest Radiol; 1980; 15(3):234-41. PubMed ID: 7399847
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intravenous urography with low-osmolality contrast agents: theoretical considerations and clinical findings.
    Dawson P; Heron C; Marshall J
    Clin Radiol; 1984 May; 35(3):173-5. PubMed ID: 6713791
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Iopamidol: a new contrast medium in coronary angiography. Comparison, on electrophysiological changes in man, with a commonly used contrast medium.
    Niccoli L; Bellandi M; Benedini G; Cuccia C; Petroboni V; Visioli O
    Eur Heart J; 1983 Apr; 4(4):280-5. PubMed ID: 6884375
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Myelography with axial tomography and a new contrast medium: iopamidol (B 15,000).
    Leonardi M; Fabris G; Penco T; Cecotto C; Biasizzo E
    J Neuroradiol; 1981; 8(1):55-62. PubMed ID: 7288482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.